Human SNP ID | rs399885 |
---|---|
Human chromosome | chr2 |
Human SNP position | 79460126 |
Pig chromosome | chr3 |
Pig SNP position | 67655385 |
PubMed ID | 20195266 |
---|---|
Journal | Mol Psychiatry |
Link | www.ncbi.nlm.nih.gov/pubmed/20195266 |
Study | Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs. |
Disease/Trait | Response to antipsychotic treatment |
Initial sample | 421 European ancestry, 214 African American, and 103 cases |
Replication sample | NA |
Region | 2p12 |
Chromosome id | chr2 |
Chromosome position | 79460126 |
Reported gene | intergenic |
Mapped gene | LOC105374823 - LOC101927987 |
Upstream gene id | 105374823 |
Downstream gene id | 101927987 |
SNP gene ids | |
Upstream gene distance | 167270 |
Downstream gene distance | 33590 |
SNP risk allele | rs399885-? |
SNPs | rs399885 |
Merged | 0 |
SNP id current | 399885 |
Context | intron_variant |
Intergenic | 1 |
Allele frequency | 0.327 |
P value | 0.0000005 |
Pvalue mlog | 6.30102999566398 |
P value text | (clozapine-heart rate) |
Or beta | |
%95 Ci | |
Platform | Affymetrix [492900] |
CNV | N |
Mapped trait | response to clozapine |
Mapped trait URI | http://purl.obolibrary.org/obo/GO_0097338 |
Study accession | GCST000618 |